Weeks 12 through 24 represent the fastest velocity phase (reaching 15 to 18% cumulative)
They lower blood glucose levels, slow gastric emptying, lower serum cholesterol and triglyceride levels, reduce liver fat content, decrease the highly inflammatory visceral fat, enhance microvascular (!) blood flows in the muscle tissue, reduce muscle-produced inflammation, microglial activation (neuroinflammation), and enhance neuroplasticity
The theoretical advantage is that the GLP-1 agonist manages caloric intake while the GH secretagogue preserves lean mass and enhances lipolysis
Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy
9,58 Tirzepatide has recently been evaluated in the SUMMIT trial
The timing of symptoms is diagnostically important